Investors & Partnership
We are moving our unique technology from the lab to the clinic to break down cancer defenses and help patients faster. We invite partners and investors to join us in building a strong future and bringing these new medicines to market.
Investment Opportunity
Backed by a seasoned management team and a breakthrough first-in-class pipeline, BiPER Therapeutics is positioned for significant growth.
With secured Seed financing and strong non-dilutive support, we are executing a strategic development plan focused on delivering key clinical and preclinical milestones.
We invite visionary investors to join our next phase of expansion.
Strategic Partnerships
We actively seek collaborations with pharmaceutical and biotech leaders aiming to strengthen their pipelines. Our BiP-targeting technology offers unique synergy potential, particularly in combination strategies designed to overcome drug resistance and revitalize standard-of-care therapies.
One Pager
Know more
Academic Collaboration
Our pipeline is powered by extensive collaborations with premier academic centers. These alliances provide rigorous scientific validation and accelerate the translation of our discoveries into clinical candidates.
Let’s Pioneer the Future of Treatment
We are always open to discussing new synergies and collaborative opportunities.